Author:
Martora Fabrizio,Annunziata Maria Carmela,Guerriero Luigi,Battista Teresa,Potestio Luca,Megna Matteo
Reference10 articles.
1. The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial;Ritchlin;Trials,2023
2. Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: a Review of the Real-World Evidence;Ruggiero;Clin Cosmet Investig Dermatol,2022
3. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease;Sushama;J Cosmet Dermatol,2019
4. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study;Canu;J Eur Acad Dermatol Venereol,2021
5. Onset of vitiligo in a psoriasis patient on ixekizumab;Marasca;Dermatol Ther,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献